{
    "doi": "https://doi.org/10.1182/blood.V118.21.4047.4047",
    "article_title": "Prediction of Apheresis Peripheral Blood Stem Cell Yield Based on Pre Apheresis Absolute Peripheral Blood Stem Cell Counts, ",
    "article_date": "November 18, 2011",
    "session_type": "711. Cell Collection and Processing: Poster III",
    "abstract_text": "Abstract 4047 Stem Cell collection via apheresis is the preferred method of collecting stem cells for hematopoietic stem cell transplantation. Accurate prediction of stem cell yield is important for the planning of apheresis procedures and for the collection of adequate stem cells. Pierelli et. al. ( Vox Sanguinis 2006, 91; 126 ) proposed a mathematical formula to estimate the CD34+ dose collected on 1 st day of apheresis based on the peripheral blood (PB) CD34+ concentration pre-apheresis and the blood volume processed (BVP). Patients and Methods : We tested the predictive value of this formula in a multicenter sample of 1608 apheresis procedures performed at 5 centers (SCSP n=85, CAS n=195, HIAE n=305, China n=172, MDACC n=851). A 50% randomly selected sample of the MDACC study population was included in this analysis. Each contributing institution selected all consecutive apheresis procedures performed over a designated time frame. Baseline patient characteristics were collected including age, gender, diagnosis, mobilization regimen, complete blood counts on day of collection, and the absolute PB CD34+ counts within 24 hours of the first apheresis procedure. Subjects who did not have data on the PB CD34+ counts were not included in the analysis. Information on total BVP and CD34+ cells collected/kg was also collected. There were 694 males (59%), median age was 50 years. To facilitate comparison of results, we used the same statistical methods reported by Pierelli et. al. to assess the correlation between the actual (ay) and predicted (py) CD34+ yields, including assessment of the linear correlation between these measures and the distribution of the ay/py ratio. Results: Data on both actual and predicted yields were available for 1148 (97%) records. Overall, Pearson's correlation coefficient (r) between ay and py was 0.67, ranging from 0.67 for MDACC to 0.86 for China and CAS. Median ay/py ratio was 1.1 (0.02\u2013433) ranging from 0.99 for HIAE to 1.5 for China and CAS. To characterize the correlation between ay and py and facilitate the clinical application of our findings, we classified the actual and predicted yields as falling below (5) the conventionally acceptable collected CD34+ doses (x10 6 /Kg). Positive predictive value (PPV) of py was estimated considering the distribution of ay as the \u201cgold standard\u201d. PPV was relatively high for py >5 [85% (95% CI 81\u201389%)], average for py 5, exceeding 80% at all institutions except SCSP. Overall, 13% of cases predicted to have a CD34+ yield between 2 and 5, had an actual yield <2. This proportion varied across institutions ranging from 5% at SCSP to 28% at HIAE. Notably, the distribution of BVP (ml/Kg) was comparable across the 3 categories of ay defined above with a median of 204 (range 74\u2013263). Consistent pattern was also observed within institutions. Conclusion: Our data indicate that the formula of Pierelli et.al. is associated with high PPV for predicted CD34+ doses >5, acceptable PPV for doses<2, and relatively low PPV for doses falling between 2 and 5. The data also suggests that CD34+ yields correlate with pre-apheresis CD34+ count and are independent of BVP  N . Total 1182 . range . SCSP 85 . range . CAS 195 . range . China 172 . range . HIAE 305 . range . MDACC 425 . range . Absolute PB CD34+ \u00d7 10 6 /\u03bcl (median, range)  28  0.3\u20132735 31  4.2\u2013279 25  1.3\u20131750 14  0.3\u2013411 31  0.6\u2013604 31  2\u20132735 Weight, Kg (median, range)  72  9\u2013169 67  38\u2013143 61  9\u2013110 63  22\u2013100 73  13\u2013143 84  11\u2013169 Day 1 Blood volume processed, L (median, range)  15  3\u2013131 14  8\u201325 12  3\u201329 9.5  4.5\u201312.5 19  5\u2013131 16  8\u201327 Actual Day 1 CD34+ dose (x 10 6 /Kg), (median, range)  2.9  0.01\u2013109 2.9  0.2\u201329 3.8  0.01\u2013109 1.8  0.01\u201350 3.5  0.1\u201344 2.8  0.2\u2013101 <2  36%   27%   33%   53%   34%   33%   2\u20135  31%   40%   28%   20%   27%   39%   >5  33%   33%   38%   27%   39%   28%   Predicted Day 1 CD34+ dose (\u00d7 10 6 /Kg), (median, range)  2.4  0.02\u2013211 2.6  0.3\u201324 2.2  0.1\u201373 0.96  0.02\u201325 3.2  0.1\u201367 2.4  0.1\u2013211 <2  44%   45%   44%   63%   33%   42%   2\u20135  30%   25%   37%   17%   28%   35%   >5  27%   30%   19%   20%   38%   23%   Ratio CD34+ dose collected/predicted  1.1  0.02\u2013433 1.1  0.2\u201311 1.5  0.03\u20136.3 1.5  0.02\u2013433 0.99  0.04\u201312 1.1  0.1\u20139.9 Pearson's correlation coefficient  0.67   0.83   0.86   0.86   0.77   0.67   Pearson's within Predicted Day 1 dose              <2  0.42   0.08   0.63   0.5   0.57   0.28   2\u20135  0.28   0.25   0.28   0.2   0.36   0.25   >5  0.56   0.77   0.81   0.7   0.63   0.6   N . Total 1182 . range . SCSP 85 . range . CAS 195 . range . China 172 . range . HIAE 305 . range . MDACC 425 . range . Absolute PB CD34+ \u00d7 10 6 /\u03bcl (median, range)  28  0.3\u20132735 31  4.2\u2013279 25  1.3\u20131750 14  0.3\u2013411 31  0.6\u2013604 31  2\u20132735 Weight, Kg (median, range)  72  9\u2013169 67  38\u2013143 61  9\u2013110 63  22\u2013100 73  13\u2013143 84  11\u2013169 Day 1 Blood volume processed, L (median, range)  15  3\u2013131 14  8\u201325 12  3\u201329 9.5  4.5\u201312.5 19  5\u2013131 16  8\u201327 Actual Day 1 CD34+ dose (x 10 6 /Kg), (median, range)  2.9  0.01\u2013109 2.9  0.2\u201329 3.8  0.01\u2013109 1.8  0.01\u201350 3.5  0.1\u201344 2.8  0.2\u2013101 <2  36%   27%   33%   53%   34%   33%   2\u20135  31%   40%   28%   20%   27%   39%   >5  33%   33%   38%   27%   39%   28%   Predicted Day 1 CD34+ dose (\u00d7 10 6 /Kg), (median, range)  2.4  0.02\u2013211 2.6  0.3\u201324 2.2  0.1\u201373 0.96  0.02\u201325 3.2  0.1\u201367 2.4  0.1\u2013211 <2  44%   45%   44%   63%   33%   42%   2\u20135  30%   25%   37%   17%   28%   35%   >5  27%   30%   19%   20%   38%   23%   Ratio CD34+ dose collected/predicted  1.1  0.02\u2013433 1.1  0.2\u201311 1.5  0.03\u20136.3 1.5  0.02\u2013433 0.99  0.04\u201312 1.1  0.1\u20139.9 Pearson's correlation coefficient  0.67   0.83   0.86   0.86   0.77   0.67   Pearson's within Predicted Day 1 dose              <2  0.42   0.08   0.63   0.5   0.57   0.28   2\u20135  0.28   0.25   0.28   0.2   0.36   0.25   >5  0.56   0.77   0.81   0.7   0.63   0.6   View Large Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "apheresis",
        "peripheral blood stem cells",
        "gold standard",
        "hematopoietic stem cell transplantation",
        "stem cell harvesting",
        "complete blood count",
        "china",
        "stem cells",
        "mathematics"
    ],
    "author_names": [
        "Timoleon Anguita, MD",
        "Alexandre Chiattone, MD",
        "Nelson Hamerschlak, MD",
        "Rima M Saliba, PhD",
        "XiaoWen Tang, MD",
        "Depei Wu, MD",
        "Alejandro Majilis, MD",
        "Araci M. Sakashita, MD",
        "Viviane C. Chiattone, RN",
        "Jose C. Barros, MD",
        "Carlos S Chiattone, MD, PhD",
        "Jose Mauro Kutner, MD, PhD",
        "Morgani Rodrigues, MD",
        "Andrea Tiemi Kondo, MD",
        "Grace-Julia Okoroji",
        "Claudia Mac-Donald Bley do Nascimento, MD",
        "Juliana Folloni Fernandes, MD",
        "Uday Popat, MD",
        "Richard E Champlin, MD",
        "Paolo Anderlini, MD",
        "Marcos De Lima, MD",
        "Chitra M Hosing, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Timoleon Anguita, MD",
            "author_affiliations": [
                "Hematology, Clinica Alemana, Santiago, Chile, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Alexandre Chiattone, MD",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nelson Hamerschlak, MD",
            "author_affiliations": [
                "Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rima M Saliba, PhD",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "XiaoWen Tang, MD",
            "author_affiliations": [
                "Hematology, The First Affiliated Hosp. of Soochow Univ.,Jiangsu Inst. of Hematology, Suzhou, China, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Depei Wu, MD",
            "author_affiliations": [
                "Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, China, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alejandro Majilis, MD",
            "author_affiliations": [
                "Hematology, Clinica Alemana, Santiago, Chile, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Araci M. Sakashita, MD",
            "author_affiliations": [
                "Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Viviane C. Chiattone, RN",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, M. D. Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose C. Barros, MD",
            "author_affiliations": [
                "Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos S Chiattone, MD, PhD",
            "author_affiliations": [
                "Hematology and Oncology, Santa Casa Medical School, Sao Paulo, Brazil, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jose Mauro Kutner, MD, PhD",
            "author_affiliations": [
                "Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Morgani Rodrigues, MD",
            "author_affiliations": [
                "Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Tiemi Kondo, MD",
            "author_affiliations": [
                "Hematology, Hospital Israelita Albert Einstein, Sao Paolo, Brazil, "
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Grace-Julia Okoroji",
            "author_affiliations": [
                "Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudia Mac-Donald Bley do Nascimento, MD",
            "author_affiliations": [
                "Dept. of Hematology, Hospital Israelita Albert Einstein, Sa\u0303o Paulo, Brazil, "
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juliana Folloni Fernandes, MD",
            "author_affiliations": [
                "Hospital Israelita Albert Einstein, Sao Paolo, Brazil, "
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Uday Popat, MD",
            "author_affiliations": [
                "UT MD Anderson Canc. Cntr., Houston, TX, USA, "
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Richard E Champlin, MD",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Paolo Anderlini, MD",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marcos De Lima, MD",
            "author_affiliations": [
                "Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Chitra M Hosing, MD",
            "author_affiliations": [
                "Department of Stem Cell Transplantation and Cellular Therapy, M. D. Anderson Cancer Center, Houston, TX, USA, "
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-18T06:42:36",
    "is_scraped": "1"
}